Dr. Marissa Kellogg, MD, MPH

Claim this profile

VA Portland Health Care System

Studies Epilepsy
Studies Cognitive Impairment
1 reported clinical trial
2 drugs studied

Affiliated Hospitals

Image of trial facility.
VA Portland Health Care System, Portland, OR

Clinical Trials Marissa Kellogg, MD, MPH is currently running

Image of trial facility.

Methylphenidate

for Epilepsy-Related Cognitive Deficits

Methylphenidate (MPH) is a stimulant, FDA-approved for the treatment of attention deficit hyperactivity disorder (ADHD). It is unknown, however, if stimulants would be of benefit for memory and thinking problems due to epilepsy. In this study, participants will be assigned randomly (i.e., by flip of a coin), to a group that takes MPH and a group that takes a placebo (sugar pill). Participants will not know the group to which they have been assigned. Tests of attention and memory will be completed before taking the study pills and at Week 8. All participants will then have the option of taking MPH for the next two months, and attention and memory will be tested again at Week 16. The study will determine whether methylphenidate is helpful for the treatment of attention and memory problems in adults with epilepsy, and whether the medication is safe and beneficial when taken over an extended time period.
Recruiting3 awards Phase 44 criteria

More about Marissa Kellogg, MD, MPH

Clinical Trial Related1 year of experience running clinical trials · Led 1 trial as a Principal Investigator · 1 Active Clinical Trial
Treatments Marissa Kellogg, MD, MPH has experience with
  • Methylphenidate
  • Placebo
Breakdown of trials Marissa Kellogg, MD, MPH has run
Epilepsy
Cognitive Impairment
Cognitive Disorders

Other Doctors you might be interested in

Rebecca I. Spain, MD MSPHVA Portland Health Care System, Portland, OR
Linda Humphrey, MDVA Portland Health Care System, Portland, OR
Lauren M. Denneson, PhDVA Portland Health Care System, Portland, OR

Frequently asked questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Marissa Kellogg, MD, MPH specialize in?
Marissa Kellogg, MD, MPH focuses on Epilepsy and Cognitive Impairment. In particular, much of their work with Epilepsy has involved treating patients, or patients who are undergoing treatment.
Is Marissa Kellogg, MD, MPH currently recruiting for clinical trials?
Yes, Marissa Kellogg, MD, MPH is currently recruiting for 1 clinical trial in Portland Oregon. If you're interested in participating, you should apply.
Are there any treatments that Marissa Kellogg, MD, MPH has studied deeply?
Yes, Marissa Kellogg, MD, MPH has studied treatments such as Methylphenidate, Placebo.
What is the best way to schedule an appointment with Marissa Kellogg, MD, MPH?
Apply for one of the trials that Marissa Kellogg, MD, MPH is conducting.
What is the office address of Marissa Kellogg, MD, MPH?
The office of Marissa Kellogg, MD, MPH is located at: VA Portland Health Care System, Portland, Oregon 97239 United States. This is the address for their practice at the VA Portland Health Care System.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top